Home » Topics » Regulatory

Regulatory
RSS

Insulin sensitizer-anorectic combinations disclosed by Takeda for NIDDM

Feb. 10, 2000

Targretin gel formulation granted priority review status

Feb. 9, 2000

Rhinocort Aqua available across U.S. for allergy relief

Feb. 9, 2000

Cephalon's Provigil beneficial in sleep apnea

Feb. 9, 2000

Boehringer Ingelheim seeks approval for combination hypertension treatments

Feb. 8, 2000

Levaquin as the first antimicrobial for CAP caused by resistant S. pneumoniae

Feb. 7, 2000

Restenosis prevention trial of tranilast is largest ever

Feb. 7, 2000

COX-2 inhibitor now available for FAP indication

Feb. 4, 2000

Sporanox Injection now available for treatment of serious fungal infections

Feb. 4, 2000

IND filed for nasal leuprolide as endometriosis therapy

Feb. 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.